Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahide Yamamoto

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Chemical Physics|September 17, 2005
Photoinduced intramolecular charge separation in a polymer solid below the glass transition temperatureHiroaki Benten, Hideo Ohkita, Shinzaburo Ito, et al.
International Journal of Hematology|August 6, 2025
Management of inpatient chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell malignancies: an analysis using the Japanese Diagnosis Procedure Combination databaseKeisuke Tanaka, Hiroaki Kikuchi, Yoshihiro Umezawa, et al.
International Journal of Hematology|April 4, 2009
Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCRMasahide Yamamoto, Kazuhiko Kakihana, Kazuteru Ohashi, et al.
Annals of Hematology|July 7, 2026
Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological eventAsuka Kono, Yoshihiro Umezawa, Kensuke Oshima, et al.
Frontiers in Immunology|July 23, 2024
An early regulatory mechanism of hyperinflammation by restricting monocyte contributionMegumi Akiyama, Masashi Kanayama, Yoshihiro Umezawa, et al.
Internal Medicine (Tokyo, Japan)|June 13, 2012
Poor outcome of myeloablative conditioned allogeneic bone marrow transplantation for myelofibrosisMasahide Yamamoto, Kazuteru Ohashi, Yuka Hirashima, et al.
Oncology Letters|July 12, 2017
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case reportKeisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Impaired hematopoiesis due to copper deficiency in a hemodialysis patient supplemented with zinc]Satoshi Koi, Kosuke Arai, Ayako Nogami, et al.
Internal Medicine (Tokyo, Japan)|March 20, 2015
Therapy-related leukemia with Inv(16)(p13.1q22) and type D CBFB/MYH11 developing after exposure to irinotecan-containing chemoradiotherapyHiroki Akiyama, Masahide Yamamoto, Chizuko Sakashita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2016
[Fulminant visceral disseminated varicella-zoster virus infection without skin involvement in a patient with autoimmune hemolytic anemia on prednisolone therapy]Megumi Akiyama, Kota Yoshifuji, Tetsuya Fukuda, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Chemical Physics|September 17, 2005
Photoinduced intramolecular charge separation in a polymer solid below the glass transition temperatureHiroaki Benten, Hideo Ohkita, Shinzaburo Ito, et al.
International Journal of Hematology|August 6, 2025
Management of inpatient chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell malignancies: an analysis using the Japanese Diagnosis Procedure Combination databaseKeisuke Tanaka, Hiroaki Kikuchi, Yoshihiro Umezawa, et al.
International Journal of Hematology|April 4, 2009
Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCRMasahide Yamamoto, Kazuhiko Kakihana, Kazuteru Ohashi, et al.
Annals of Hematology|July 7, 2026
Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological eventAsuka Kono, Yoshihiro Umezawa, Kensuke Oshima, et al.
Frontiers in Immunology|July 23, 2024
An early regulatory mechanism of hyperinflammation by restricting monocyte contributionMegumi Akiyama, Masashi Kanayama, Yoshihiro Umezawa, et al.
Internal Medicine (Tokyo, Japan)|June 13, 2012
Poor outcome of myeloablative conditioned allogeneic bone marrow transplantation for myelofibrosisMasahide Yamamoto, Kazuteru Ohashi, Yuka Hirashima, et al.
Oncology Letters|July 12, 2017
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case reportKeisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Impaired hematopoiesis due to copper deficiency in a hemodialysis patient supplemented with zinc]Satoshi Koi, Kosuke Arai, Ayako Nogami, et al.
Internal Medicine (Tokyo, Japan)|March 20, 2015
Therapy-related leukemia with Inv(16)(p13.1q22) and type D CBFB/MYH11 developing after exposure to irinotecan-containing chemoradiotherapyHiroki Akiyama, Masahide Yamamoto, Chizuko Sakashita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2016
[Fulminant visceral disseminated varicella-zoster virus infection without skin involvement in a patient with autoimmune hemolytic anemia on prednisolone therapy]Megumi Akiyama, Kota Yoshifuji, Tetsuya Fukuda, et al.
Pageof 8